Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Liqun Yu, Keziah Liebenberg, Yichao Shen, Fengshuo Liu, Zhan Xu, Xiaoxin Hao, Ling Wu, Weijie Zhang, Hilda L. Chan, Bo Wei, Philip L. Lorenzi, Yang Gao, Igor Bado, Luis Becerra-Dominguez, Charlotte Helena Rivas, Sergio Aguirre, Bradley C. Pingel, Yi-Hsuan Wu, Yunfeng Ding, Jun Liu, David G. Edwards, Lívia S. Eberlin, Xiang H.-F. Zhang
Topics & Concepts
BiologyArachidonic acidImmune systemBreast cancerTriple-negative breast cancerImmunologyCancer researchCancerCancer therapyImmunityResistance (ecology)GeneticsBiochemistryEnzymeEcologyImmune cells in cancerChemokine receptors and signalingNeutrophil, Myeloperoxidase and Oxidative Mechanisms